Antidiabetic Effect of Ethanol Extract of Keji beling Leaves (Strobhilantes crispa) in Rats Induced by Streptozotocin

Authors

  • Nuraqidah Nuraqidah Master of Pharmacy program, Post graduate program, Universitas Muslim Indonesia Jl. Urip Sumoharjo Km 05 Makassar Sulawesi Selatan, Indonesia, Indonesia
  • Hasnaeni Hasnaeni Magister Farmasi, Pasca sarjana Farmasi Universitas Muslim Indonesia, Indonesia
  • Mirawati Mirawati Master of Pharmacy program, Post graduate program, Universitas Muslim Indonesia Jl. Urip Sumoharjo Km 05 Makassar Sulawesi Selatan, Indonesia, Indonesia

DOI:

https://doi.org/10.33394/hjkk.v12i5.13256

Keywords:

antidiabetic, hyperglycemic, keji beling (Strobhilantes crispa) extract, DM type

Abstract

Diabetes Mellitus (DM) type 2 is a chronic disease characterized by increased glucose levels in the body due to insulin resistance or inadequate insulin production. This study aims to determine the antidiabetic potential of keji beling ( Strobhilantes crispa) leaf extract. This research is different from other studies which used Alloxan as a diabetes inducer. In this study, Streptozotocin was used as a DM inducer. After treatment, information was obtained that keji beling (S. crispa) extract could reduce blood glucose levels in type 2 DM rats. Experimental research used 30 male Wistar rats divided into six groups consisting of normal group, negative control (HFD and Streptozotocin), positive control (Glibenclamide), dose group I (150 mg/kg BW), dose II (300 mg/ kg BW), and dose III (450 mg/kg BW). Based on the research results, it is known that S.crispa leaf extract can reduce blood glucose levels in mice induced by Streptozotocin and has the potential to act as an antihyperglycemic in type 2 DM.

References

Andi Melvi Reski Ananda, Hasnaeni, Rezki Amriati ., Skripsi Pemisahan senyawa flavonoid pada tanaman keji beling (strobhilantes crispa), Fakultas Farmasi Universitas Muslim Indonesia

American Diabetes Association. (2017). Standards of medical care in diabetes 2017. Diabetes Care, 40(1), 1–8

Brata, A., Azizah, L., & Muin, D. (2023). The Effectiveness Of Using Bengkal Leaf Infusion (Nauclea Orientalis L.) As An Antidiabetic For Mice. Jurnal Bahana Kesehatan Masyarakat (Bahana of Journal Public Health), 7(2), 75–81

Ghasemzadeh, A., Jaafar, H., Rahmat, A., (2015). Phytochemical constituents and biological activities of different extracts of Strobilanthes crispus (L.) Bremek leaves grown in different locations of Malaysia, 15 (422), 1-10

Hartanti, D., & Budipramana, K. (2020). Traditional antidiabetic plants from indonesia. Ethnobotany Research and Applications, 19(1), 1–12

Hasnaeni and Aminah. (2019). “Uji Aktivitas Antioksidan Dan Profil Fitokimia Ekstrak Kayu Beta-Beta (Lunasia Amara Blanco.).†Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) 5(1): 101–7

IDF. (2021). International Diabetic Federation Diabetic Atlas 10th edition

Malingkay, H. P., Rumondor, R., & Walean, M. (2018). Uji efektifitas antidiabetes ekstrak etanol kulit buah manggis (Garcinia mangostana L) pada tikus putih (Rattus norvegicus) yang diinduksi aloksan. Chemistry Progress, 11 (1), 15– 20

Menant M., (1980). Medicinal plants of east and south east Asia. Cambridge, UK: MIT Pres

Natanael R, Aditya Y, widya A. L. 2017. Standarisasi Parameter Spesifik dan Uji Aktivitas Antikanker terhadap Sel Kanker Payudara T47D dari Ekstrak Etanol Daun Keji Beling (Strobilanthes crispa (L.) Blume). Pharmacon. 6: 181

Ojuade, F. I., Olorundare, O. E., Akanbi, O. B., Afolabi, S. O., & Njan, A. A. (2021). Antidiabetic and antihyperlipidemic effects of aqueous extract of Parquetina nigrescens in streptozotocin–nicotinamide induced type 2 diabetic rats. Heliyon, 7(6), 1–7

Palit, F., Tiwow, G., Maarisit, Wilmar., Karundeng, E., Karauwan, F. (2018). Uji aktivitas antidiabetes ekstrak etanol daun keji beling stobilanthes crispa blume pada tikus putih rattus norvegicus yang diinduksi aloksan., Jurnal Biofarmasetikal Tropis, 1 (1), 1-4

Panjuatiningrum, F., 2009. Pengaruh Pemberian Buah Naga Merah (Hylocereus polyrhizus) Terhadap Kadar Glukosa Darah Tikus Putih yang Diinduksi Aloksan, Fakultas Kedokteran, Universitas Sebelas Maret, Surakarta

Roussel, T. N. G., Martin, F., Aimé, Y. F. J., Lanvin, E. E. F. W., Boris, A. K., Laure, N. J., & Enyong, O. J. (2022). Antihyperglycemic and antihyperlipidemic activities of hydroethanolic extract of the fruit of Baillonella toxisperma in streptozotocin-induced diabetic rats. Metabolism Open, 15(2), 1–19

Ruswanto., Mardianingrum, R., Lestari, T., Nofianti, T., Tuslinah, L., Nurmalik, D. (2018). In silico study of the active compounds in bitter melon(Momordica charantia L) as antidiabeticmedication. Jurnal Pharmaciana, 8(2), 177-194

Samal, Pradeep Kumar. (2013). Antidiabetic and antioksidant activity of Strobilanthes asperrimus in rats. Journal of Global Trens In Pharmaceutical Seciences, 4(2): 1067-1072

Saputra, N. T., Suartha, I., Dharmayudha, A. A. G. O., (2018). Agen Diabetagonik Streptozotocin untuk Membuat Tikus Putih Jantan Diabetes Mellitus. Buletin Veteriner Udayana Volume 10 No. 22477-2712

Sun, J. W., Hernández-Díaz, S., Bourgeois, F. T., Haneuse, S., Brill, G., Bateman, B. T., & Huybrechts, K. F. (2021). Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019. Diabetes, Obesity and Metabolism, 23(2), 1–9

Ta Larasati., Meiwa, R., Putri, R. A. B., (2021). Uji Efektivitas Daun Keji Beling (Strobilanthes crispus [Sinonim=Sericocalyx crispus L]) sebagai Anti Diabetes Mellitus., Ilmu Kesehatan Komunitas, Fakultas Kedokteran, Universitas Lampung Fakultas Kedokteran, Universitas Lampung

Downloads

Published

2024-10-31

How to Cite

Nuraqidah, N., Hasnaeni, H., & Mirawati, M. (2024). Antidiabetic Effect of Ethanol Extract of Keji beling Leaves (Strobhilantes crispa) in Rats Induced by Streptozotocin. Hydrogen: Jurnal Kependidikan Kimia, 12(5), 1146–1151. https://doi.org/10.33394/hjkk.v12i5.13256

Issue

Vol. 12 No. 5 (2024): October 2024

Section

Articles

Citation Check

License

License and Publishing Agreement
In submitting the manuscript to the journal, the authors certify that:

  1. They are authorized by their co-authors to enter into these arrangements.
  2. The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
  3. That it is not under consideration for publication elsewhere,
  4. That its publication has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
  5. They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
  6. They agree to the following license and publishing agreement.

Copyright
Authors who publish with Hydrogen: Jurnal Kependidikan Kimia agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Licensing for Data Publication

Hydrogen: Jurnal Kependidikan Kimia uses a variety of waivers and licenses, that are specifically designed for and appropriate for the treatment of data: Open Data Commons Attribution License, http://www.opendatacommons.org/licenses/by/1.0/ (default) Other data publishing licenses may be allowed as exceptions (subject to approval by the editor on a case-by-case basis) and should be justified with a written statement from the author, which will be published with the article.